Distribution Agreement in Australia for new needle-free drug delivery system

The Medical House PLC (“TMH”), the medical equipment and devices company, announces that it has signed a distribution agreement with Roth Medical Components Australia (Pty) Ltd (Roth Medical Components) for the distribution in Australia of its new needle-free drug delivery system for the delivery of insulin. According to the W.H.O there were over 900,000 people diagnosed with diabetes in Australia in the year 2000.

TMH announced on 8 May 2003 that its new needle-free drug delivery system had been awarded the CE Mark. The agreement with Roth Medical Components will become effective following the regulatory process in Australia to approve the use of the CE marked device for the delivery of insulin. This process is expected to be completed during the current calendar year.

The agreement will run for an initial period of three years from the effective date on an exclusive basis in Australia. Based on indicative quantities, the sales of devices together with escalating sales of the associated consumables could give rise to revenues over the three-year period in excess of £700,000.

Roth Medical Components is a private company based in Australia with a number of regional offices and coverage across the country. It is involved in the marketing of a range of medical devices.

Chief Executive of TMH, Ian Townsend, said:
“Our needle-free devices have generated a number of enquiries since receiving drug tariff approval for mhi-500 and continues to be well received by potential commercial partners. This is the second commercial agreement for the new device since gaining approval just a few months ago. So far this year we have concluded five distribution agreements for our range of needle-free systems across a number of countries in both northern and southern hemisphere territories. Our needle-free devices continue to gain acceptance as a clear viable alternative to the needle.”

Notes to Editors

The Medical House PLC (“TMH”) is quoted on AIM and specialises in the design, manufacture and distribution of medical devices and equipment. Its operations include: Eurocut, a company specialising in the design, development and manufacture of instruments for use in orthopaedic surgery; Creative Medical Design, a leading designer of medical devices and manufacturer of prototypes; and Medical House Products which undertakes the development and subsequent sale of medical devices.

Roth Medical Components Australia (Pty) Ltd is a subsidiary of Roth Medical Components (Pty) Ltd, based in South Africa. This company, which was established in 1992, designs and manufactures medical devices and holds numerous international patents. It is also the parent company of Triple M Multi Medical Marketing (Pty) Ltd with whom TMH announced on 20 May 2003 the signing of a distribution agreement for the distribution of its new needle-free drug delivery system for the delivery of insulin in the Southern African Development Community.

- Ends -

Contacts:
Ian Townsend, Chief Executive
tel: 0114 261 9011
The Medical House PLC
www.themedicalhouse.com

John Bick, Holborn
tel: 020 7929 5599